Restoration of p53 function in anaplastic Wilms' tumor

Journal of Pediatric Surgery

Volumn 36, Issue 1, 2001, Pages 43-50

  Delatte, Stephen J ^a   Hazen Martin, Debra J ^a   Re, Gian G ^a   Kelly, Joseph R ^a   Sutphin, Aimee ^a   Tagge, Edward P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anaplastic; Gene therapy; Nephroblastoma; p53; Wilms' tumor

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANAPLASTIC CARCINOMA; APOPTOSIS; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; GENE MUTATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0035166389     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2001.20002     Document Type: Conference Paper

References (38)

1. Cancer statistics, 2000
2. Nephroblastoma (Wilms' tumor): A model system of aberrant renal development
3. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors
4. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line
5. Treatment of children with stages II to IV anaplastic Wilms' tumor: A report from the National Wilms' Tumor Study Group
6. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations
7. Mutations of p53 in Wilms' tumors
8. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations
9. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor
10. Expression of a multidrug-resistance gene in human tumors and tissues
11. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants
12. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
13. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor
14. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck
15. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
16. Adenovirus-based p53 gene therapy in ovarian cancer
17. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation
18. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer
19. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer
20. Analytical anion-exchange Hplc of recombinant type-5 adenoviral particles
21. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
22. The p53 pathway and apoptosis
23. Restoration of tumour suppressor gene expression for cancer
24. P53 tumor suppressor gene therapy for cancer
25. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
26. p53 mutations in human cancers
27. p53 protein expression in nephroblastomas: A predictor of poor prognosis
28. The yin and yang of p53 in cellular proliferation
29. Inquiry into gene therapy widens
30. Gene therapy investigations proliferate
31. FDA puts US gene-therapy trial on hold
32. Gene therapy: A rocky start to the new millennium
33. NIH tightens up monitoring of gene-therapy mishaps
34. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
35. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement
36. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers
37. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma